A Six-Gene Signature Predicts Survival of Patients with Localized Pancreatic Ductal Adenocarcinoma

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) remains a lethal disease. For patients with localized PDAC, surgery is the best option, but with a median survival of less than 2 years and a difficult and prolonged postoperative course for most, there is an urgent need to better identify patients...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Stratford, Jeran K., Bentrem, David J., Anderson, Judy M., Fan, Cheng, Volmar, Keith A., Marron, J. S., Routh, Elizabeth D., Caskey, Laura S., Samuel, Jonathan C., Der, Channing J., Thorne, Leigh B., Calvo, Benjamin F., Kim, Hong Jin, Talamonti, Mark S., Iacobuzio-Donahue, Christine A., Hollingsworth, Michael A., Perou, Charles M., Yeh, Jen Jen
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2010
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903589/
https://ncbi.nlm.nih.gov/pubmed/20644708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1000307
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki